Black women face systemic issues accessing gynecological care. A physician-scientist outlines her vision to improve ...
Forbes contributors publish independent expert analyses and insights. Geri Stengel writes about the success factors of women entrepreneurs. For decades, women seeking long-acting birth control have ...
In recent years, a growing outcry has drawn long-overdue attention to a difficult truth: girls’ and women’s pain has too often been dismissed and undertreated in medicine. A 2022 study found that most ...
Contraline — a trailblazer in the nascent male contraceptive market — released promising new trial data on Thursday showing that the company’s contraceptive hydrogel has demonstrated safety and ...
U.S. District Chief Judge Leigh Martin May of the Northern District of Georgia planned a hearing Tuesday on whether to move ahead with the bellwether plan after a federal jury sided with defendant ...
Retained intrauterine devices (IUDs) after menopause are common in China, yet their complications may be clinically silent. Uterine atrophy and rigid open-frame designs can permit gradual transmural ...
Teva faces over 3,800 lawsuits over Paragard IUD claims Trial was the first bellwether to test the claims Teva sold Paragard to CooperSurgical in 2017 Feb 4 (Reuters) - A jury in Atlanta federal court ...
WHIPPANY, N.J.--(BUSINESS WIRE)-- Bayer announced today the start of its Phase III study SUNFLOWER, an investigational study evaluating the efficacy and safety of 52mg levonorgestrel-releasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results